LAKE OSWEGO, Ore., May 31, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced the appointment of Gabriel N. Hortobagyi, M.D., F.A.C.P, to the Company’s Scientific Advisory Board (SAB).
